VIDEO: Investigational topical antifungals target onychomycosis

WAIKOLA, HAWAII – Two topical antifungals that are designed to treat onychomycosis may reach the U.S. market within the next year, according to nail expert Dr. Phoebe Rich.

"It’s very exciting that we finally have some new medications for onychomycosis," said Dr. Rich of Oregon Dermatology and Research Center, Portland. She spoke with us about the two agents – tavaborole and efinaconazole – in a video interview during the SDEF Hawaii Dermatology Seminar.

WAIKOLA, HAWAII – Two topical antifungals that are designed to treat onychomycosis may reach the U.S. market within the next year, according to nail expert Dr. Phoebe Rich.

"It’s very exciting that we finally have some new medications for onychomycosis," said Dr. Rich of Oregon Dermatology and Research Center, Portland. She spoke with us about the two agents – tavaborole and efinaconazole – in a video interview during the SDEF Hawaii Dermatology Seminar.

WAIKOLA, HAWAII – Two topical antifungals that are designed to treat onychomycosis may reach the U.S. market within the next year, according to nail expert Dr. Phoebe Rich.

"It’s very exciting that we finally have some new medications for onychomycosis," said Dr. Rich of Oregon Dermatology and Research Center, Portland. She spoke with us about the two agents – tavaborole and efinaconazole – in a video interview during the SDEF Hawaii Dermatology Seminar.